Printer Friendly
The Free Library
14,506,237 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BRT Laboratories, Inc. Has Been Approved as a Clinical Trial Testing Facility for OncoMethylome Sciences' Participation in a Multi-Site, International Clinical Trial.


BALTIMORE -- BRT BRT Bus Rapid Transit
BRT Business Roundtable
BRT Brightness
BRT Be Right There (chat)
BRT Bruttoregistertonnen (German: Gross Register Tons)
BRT Biratnagar (Nepal) 
 Laboratories, Inc. Has Been Contracted By OncoMethylome Sciences, To Perform MGMT MGMT Management
MGMT Methyl Guanine Methyl Transferase
MGMT Make Good a Magnetic Track of ___ Degrees
 Methylation methylation,
n a phase-II detoxification pathway in the liver; methyl groups combine with toxins to rid the body of various substances.

methylation
(meth´
 Assays for a Multi-Site, International Clinical Trial

BRT Laboratories, Inc. announced today that the laboratory has been approved by the clinical trial supporter and OncoMethylome Science's collaborator, Schering-Plough Corporation, to provide MGMT methylation testing for OncoMethylome Sciences. Starting immediately, the laboratory will be evaluating the methylation status of the MGMT gene in DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 extracted from brain tumor cells using OncoMethylome Sciences' patent-protected assay.

This is an important first step in the ongoing collaboration between BRT Laboratories, Inc. and OncoMethylome Sciences that was announced on March 29, 2006. Making this testing service available is a key milestone in OncoMethylome Sciences' collaboration with Schering-Plough, which was announced on November 11, 2005. The tumor samples will originate from the multi-center brain cancer clinical trial conducted by the U.S.-based Radiation Therapy Oncology Group (RTOG RTOG Radiation Therapy Oncology Group
RTOG Round Table of Goodness (diecast toy car collecting club) 
), the European Organization for Research and Treatment of Cancer (EORTC EORTC European Organization for Research and Treatment of Cancer ), and supported by Schering-Plough.

ABOUT BRT LABORATORIES, INC.

BRT Laboratories, Inc., a Baltimore based biotech company, is a multi-faceted laboratory offering a full range of genetic services that includes relationship analysis, identity testing, and clinical assay development. BRT has been serving the community for over 60 years in the areas of paternity, immigration immigration, entrance of a person (an alien) into a new country for the purpose of establishing permanent residence. Motives for immigration, like those for migration generally, are often economic, although religious or political factors may be very important. , forensics, and blood donor services.

BRT also offers services for the development and validation of diagnostic and monitoring assays for the research community, provides blood cell products for research, and performs diagnostic and patient monitoring testing for physicians, hospitals, and clinical trial applications. BRT offers a full range of services that support commercial, government and academic collaborations. For more information, please visit our website at www.brtlabs.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 28, 2006
Words:277
Previous Article:Gain an Insight into the World's AC/DC Switching Power Supplies Industry.
Next Article:Sequence Extends EM And V-drop Analysis To Full-Custom Designs; Speedview-AMS To Offer New Power-Rail Analysis Capabilities.
Topics:



Related Articles
The what's and why's of clinical trials. (includes related information)
Pilot trial of an oral interferon.
ACURIAN OPENS NEW OFFICES IN LONDON.
ACURIAN OPENS NEW OFFICES IN LONDON.
Society task force develops guidelines for placebos. (National MS Society News).(Brief Article)
Lessons learned in participant recruitment and retention: the EXCITE trial.(Perspective)
Autism Centers of Excellence (R01).(Announcements: Fellowships, Grants, & Awards)
ACM-Pivotal Undergoes Expansion due to Significant Growth in Global Central Lab Services for Clinical Trials.
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Centers.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles